SyntheticGestalt

SyntheticGestalt, founded in 2018 and headquartered in Japan, is at the forefront of innovation in the Biotechnology and Pharmaceutical industries. The company is driven by its slogan, "Scientific Research by Artificially Intelligent Agents," and has made significant strides in developing machine learning models for drug discovery. Their comprehensive software facilitates and automates research, catering to the life-sciences sector.

Supported by a strong network, SyntheticGestalt recently received backing through a Support Program investment on 01 January 2023. This strategic investment was spearheaded by J-Startup, underscoring continued confidence in the company's visionary approach and potential for growth in transforming drug discovery processes.

With a focus on advancing research methodologies through artificial intelligence, SyntheticGestalt is well-positioned to capture substantial market opportunities and drive significant impact in the biotech sphere.